Presence of prostate cells in bone marrow biopsies as a sign of micrometastasis in cancer patients

Oncology Reports

Volumn 21, Issue 3, 2009, Pages 571-575

  Murray, Nigel Peter ^a   Calaf, G M ^b,c   Badinez L ^d  

^a UNIVERSIDAD MAYOR   (Chile)

^b UNIVERSIDAD DE TARAPACÁ   (Chile)

^c Department of Medicine   (United States)

^d Institute Nacional del Cáncer   (Chile)

Author keywords

Bone marrow aspirates; Micrometastasis; Prostate cells

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATE SURGERY;

AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; BONE MARROW; BONE MARROW NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 64849103972     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000258     Document Type: Article

References (17)

1. Szot J: Epidemiological analysis of mortality caused by solid tumors in the Metropolitan Region, Chile. Rev Med Chil 131: 641-649, 2003.
2. Wood DP and Banerjee M: Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease free survival. J Clin Oncol 15: 3451-3457, 1997.
3. Cross NA, Papageorgiou M and Eaton CL: Bone marrow stromal cells promote growth and survival of prostate cancer cells. Biochem Soc Trans 35: 698-700, 2007.
4. Ye L, Lewis-Russell JM, Kynaston H and Jiang WG: Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists. J Urol 178: 1086-1091, 2007.
5. Ye L, Lewis-Russell JM, Kyanaston HG and Jiang WG: Bone morphogenetic proteins and their receptor signaling in prostate cancer. Histol Histopathol 22: 1129-1147, 2007.
6. Cher ML, De Oliveira JG, Beaman AA, Nemeth JA, Hussain M and Wood DP Jr: Cellular proliferation and prevalence of micrometastatic cells in the bone marrow of patients with clinically localized prostate cancer. Clin Cancer Res 5: 2421-2425, 1999.
7. Oberneder R, Riesenberg R, Kreigmair M, et al: Immunocytochemical detection and phenotypic characterization of micrometastatic tumor cells in bone marrow of patients with prostate cancer. Urol Res 22: 3-8, 1994.
8. Pantel K, Aignherr C, Köllermann J, Caprano J, Riethmüller G and Köllermann MW: Immunocytochemical detection of isolated tumor cells in bone marrow of patients with untreated stage C prostate cancer. Eur J Cancer 31: A1627-A1632, 1995.
9. Mueller P, Caroll P, Bowers E, et al: Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant. Cancer 83: 538-546, 1998.
10. Borgen G: Standardization of the immunocytochemical detection of cancer cells in bone marrow and blood I: Establishment of objective criteria for the evaluation of immunostained cells ISHAGE. Cytotherapy 5: 377-388, 1999.
11. Murray NP: El costo beneficio del estudio de diseminación en cáncer prostático en el uso de anticuerpos monoclonales para detectar micrometástasis en la médula ósea: una comparación con el cintigrama óseo. Rev Chil Urol 71: 200-204, 2006.
12. Askenasy N and Farkas DL: Optical imaging of PKH-labeled hematopoietic cells in recipient bone marrow in vivo. Stem Cells 20: 501-513, 2002.
13. Quesenberry PJ and Becker PS: Stem cell homing: rolling, crawling and nesting. Proc Natl Acad Sci USA 95: 15155-15157, 1998.
14. Christensen JL, Wright DE, Wagers AJ and Weissman IL: Circulation and chemotaxis of fetal hematopoietic stem cells. PLoS Biol 2: E75, 2004.
15. Mazo IB and Von Andrian UH: Adhesion and homing of bloodborne cells in bone marrow microvessels. J Leukoc Biol 66: 25-32, 1999.
16. Morrisey C and Vessella RI: The role of tumor micro-environment in prostate cancer bone metastasis. J Cell Biochem 101: 873-886, 2007.
17. Depuy V, Anstrom KJ, Castel LD, Schulman KA, Weinfurt KP and Saed F: Effects of skeletal morbidities on longitudinal patients reported outcomes and survival in patients with metastatic prostate cancer. Support Care Cancer 15: 869-876, 2007.